FibroGen slides after ‘unfavorable disclosure’ on safety data for anemia pill

Shares of FibroGen (FGEN) are under pressure on Wednesday after the company provided “clarification of certain prior disclosures of U. S… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3278861/-FibroGen-slides-after-unfavorable-disclosure-on-safety-data-for-anemia-pill)